Latest Wilshire Bancorp (WIBC) Headlines Book Profits

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Wilshire Bancorp (WIBC) Headlines

Book Profits With These 11 Community Banks
at The Street - 59 mins ago
Investors should avoid Eagle Bancorp, Home Bancshares, Investors Bancorp, Bank of the Ozarks and Signature Bank .

California Banks Are Sitting Pretty, Says KBW
at The Street - Thu Mar 06, 11:21AM CST
California banks in urban areas are well-positioned for 'robust' loan growth and revenue growth, according to KBW analyst Juliana Balicka.

Wilshire Bancorp to Participate in the Sandler O'Neill 2014 West Coast Financial Services Conference
GlobeNewswire - Tue Mar 04, 3:07PM CST
Wilshire Bancorp, Inc. (Nasdaq:WIBC), the holding company for Wilshire Bank, today announced that members of the Company's senior management team will be participating in the Sandler O'Neill 2014 West Coast Financial Services Conference on March 11, 2014 in Phoenix, AZ. Jae Whan (J.W.) Yoo, President and Chief Executive Officer, Alex Ko, Executive Vice President and Chief Financial Officer, and Peter Koh, Senior Vice President and Chief Credit Officer, will represent Wilshire Bancorp at the conference and meet with institutional investors. A copy of the investor presentation to be used at the conference will be made available on the same day on the investor relations section of the Company's website www.wilshirebank.com.

How Wilshire Bancorp (WIBC) Stock Stands Out in a Strong Industry - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Feb 25, 7:49AM CST
Wilshire Bancorp belongs to the Banking industry, will be a decent pick, as the company witnessed solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.

Wilshire Bancorp Shares Up 60.6% Since SmarTrend's Buy Recommendation (WIBC)
Comtex SmarTrend(R) - Tue Feb 18, 9:16AM CST
SmarTrend identified an Uptrend for Wilshire Bancorp (NASDAQ:WIBC) on January 9th, 2013 at $6.28. In approximately 14 months, Wilshire Bancorp has returned 60.64% as of today's recent price of $10.08.

Uptrend Call Working As Wilshire Bancorp Stock Rises 57.3% (WIBC)
Comtex SmarTrend(R) - Fri Feb 07, 9:36AM CST
SmarTrend identified an Uptrend for Wilshire Bancorp (NASDAQ:WIBC) on January 9th, 2013 at $6.28. In approximately 13 months, Wilshire Bancorp has returned 57.29% as of today's recent price of $9.87.

Upgrade Alert for Wilshire Bancorp (WIBC)
Comtex SmarTrend(R) - Tue Feb 04, 6:58AM CST
Wilshire Bancorp (NASDAQ:WIBC) was upgraded from Market Perform to Outperform at Keefe Bruyette today. The stock closed yesterday at $9.53 on volume of 646,000 shares, above average daily volume of 449,000. Potential upside of 21.7% exists for Wilshire Bancorp, based on a current level of $9.53 and analysts' average consensus price target of $11.60. The stock should find resistance at its 50-day moving average (MA) of $10.45, as well as support at its 200-day MA of $8.47.

Wilshire Bank Recognized as Largest SBA Lender in Los Angeles
GlobeNewswire - Mon Feb 03, 7:00AM CST
Wilshire Bank (the "Bank"), a subsidiary of Wilshire Bancorp, Inc. (Nasdaq:WIBC) (the "Company"), today announced that it has been recognized by the U.S. Small Business Administration as the largest producer of SBA loans in the SBA Los Angeles District (Los Angeles, Santa Barbara and Ventura Counties) for fiscal year 2013. Wilshire Bank originated 130 SBA loans totaling $46.1 million in the Los Angeles District during the SBA fiscal year ended September 30, 2013.

Uptrend Call Working As Wilshire Bancorp Stock Rises 60.2% (WIBC)
Comtex SmarTrend(R) - Fri Jan 31, 9:10AM CST
SmarTrend identified an Uptrend for Wilshire Bancorp (NASDAQ:WIBC) on January 9th, 2013 at $6.28. In approximately 13 months, Wilshire Bancorp has returned 60.16% as of today's recent price of $10.05.

Wilshire Bancorp Reports Net Income of $10.9 Million or $0.15 per Share for Fourth Quarter 2013
GlobeNewswire - Mon Jan 27, 4:58PM CST
Wilshire Bancorp, Inc. (Nasdaq:WIBC) (the "Company"), the holding company for Wilshire Bank (the "Bank"), today reported net income available to common shareholders of $10.9 million, or $0.15 per diluted common share, for the quarter ended December 31, 2013. This compares to net income available to common shareholders of $15.2 million, or $0.21 per diluted common share, for the same period of the prior year, and net income available to common shareholders of $11.3 million, or $0.16 per diluted common share, for the third quarter of 2013. Financial results for the fourth quarter of 2013 include $1.8 million in one-time merger-related expenses attributable to the acquisitions of BankAsiana and Saehan Bancorp.

Wilshire Bancorp Has Returned 72.4% Since SmarTrend Recommendation (WIBC)
Comtex SmarTrend(R) - Thu Jan 23, 4:46PM CST
SmarTrend identified an Uptrend for Wilshire Bancorp (NASDAQ:WIBC) on January 9th, 2013 at $6.28. In approximately 13 months, Wilshire Bancorp has returned 72.43% as of today's recent price of $10.82.

Wilshire Bancorp, Inc. Announces 2013 Fourth Quarter and Year End Earnings Conference Call
GlobeNewswire - Wed Jan 22, 3:00PM CST
Wilshire Bancorp, Inc. (Nasdaq:WIBC), will hold its quarterly conference call to discuss 2013 fourth quarter and year end results on Tuesday, January 28, 2014, at 11:00 A.M. PST (2:00 P.M. EST).

67.8% Return Seen to Date on SmarTrend Wilshire Bancorp Call (WIBC)
Comtex SmarTrend(R) - Thu Jan 09, 9:38AM CST
SmarTrend identified an Uptrend for Wilshire Bancorp (NASDAQ:WIBC) on January 9th, 2013 at $6.28. In approximately 12 months, Wilshire Bancorp has returned 67.81% as of today's recent price of $10.53.

Bank of Commerce Holdings (BOCH) Jumps: Stock Up 5.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed Jan 08, 8:39AM CST
Bank of Commerce Holdings was a big mover last session, as its shares rose over 5% on the day.

Uptrend Call Working As Wilshire Bancorp Stock Rises 73.1% (WIBC)
Comtex SmarTrend(R) - Thu Jan 02, 9:11AM CST
SmarTrend identified an Uptrend for Wilshire Bancorp (NASDAQ:WIBC) on January 9th, 2013 at $6.28. In approximately 12 months, Wilshire Bancorp has returned 73.07% as of today's recent price of $10.86.

Wilshire Bancorp Announces Changes to Board of Directors
GlobeNewswire - Tue Dec 31, 3:30PM CST
Wilshire Bancorp, Inc. (Nasdaq:WIBC) (the "Company"), the parent company of Wilshire Bank (the "Bank"), today announced that Kyu-Hyun Kim and Young Hi Pak will retire from both the Company's Board of Directors and the Bank's Board of Directors, effective December 31, 2013. Both Mr. Kim and Mrs. Pak served on the Board of Directors of the holding company and the Bank for 20 years.

Wilshire Bancorp Declares Quarterly Cash Dividend
GlobeNewswire - Mon Dec 30, 7:35PM CST
Wilshire Bancorp, Inc. (Nasdaq:WIBC), the parent company of Wilshire Bank, announced today that the Board of Directors has declared a quarterly cash dividend of $0.03 per common share. The dividend will be paid to all stockholders of record as of January 6, 2014, payable on January 15, 2014.

Wilshire Bancorp Up 77.4% Since SmarTrend Uptrend Call (WIBC)
Comtex SmarTrend(R) - Tue Dec 24, 4:51PM CST
SmarTrend identified an Uptrend for Wilshire Bancorp (NASDAQ:WIBC) on January 9th, 2013 at $6.28. In approximately 12 months, Wilshire Bancorp has returned 77.37% as of today's recent price of $11.13.

Wilshire Bancorp (WIBC) Stock Research Links

WIBC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 38

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 47

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 44

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 38

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 43

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 35

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Launched into AppLovin Corporation's Alleged Fraud

Updated Category News Views 386

Investigation into AppLovin Corporation In recent news, a substantial class action lawsuit has emerged against AppLovin Corporation (NASDAQ: APP). This national law firm, known for advocating for investors, aims to hold the company accountable for alleged securities law violations. Understanding the Class Action Lawsuit This lawsuit pertains to any individuals or entities...

Continue Reading
Safe Harbor Financial Expands Support for Cannabis Operators

Updated Category News Views 33

Safe Harbor Financial Takes Bold Step in Cannabis Financing In a remarkable move, Safe Harbor Financial has successfully arranged a secured credit facility valued at $1.07 million. This milestone supports a cannabis operator, marking a significant step in bolstering financial services within the cannabis industry. With their expertise in facilitating innovative financial...

Continue Reading
Nidec Corporation Faces Securities Investigation: Key Insights

Updated Category News Views 224

Understanding Nidec Corporation's Current Challenges Nidec Corporation is undergoing scrutiny due to serious allegations in its business practices. This Japanese manufacturer, known for its electronic components, faces potential claims of issuing misleading information to its investors. Recent developments have raised questions about its transparency and accountability in...

Continue Reading
Understanding HCI Group's Short Interest Trends and Insights

Updated Category News Views 126

An Overview of HCI Group's Short Interest HCI Group's short interest has sparked interest among traders and investors alike, showing a recent increase of 7.38% from the previous report. This shift indicates that there are currently around 404 thousand shares sold short, comprising 4.95% of the company’s total tradable shares. Observing the trading volume, it has been...

Continue Reading
Fresenius Kabi Introduces New Epinephrine Injection for Patients

Updated Category News Views 151

Fresenius Kabi Launches Epinephrine Injection, USP Fresenius Kabi, a proud branch of the Fresenius organization, has taken a significant step in enhancing its pharmaceutical portfolio in the United States by making available Epinephrine Injection, USP. This launch positions Fresenius Kabi at the forefront as it becomes the first company to offer a generic 1mg/1mL vial of...

Continue Reading